在帕金森病中的外科手术期间的炎症性细胞因子
Jong-Woan Kim1, Seung-Ah Yoo2, Yemi Choi2
1Department of Anesthesiology and Pain Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Biomolecules
|February 27, 2026
概括
患有帕金森病 (PD) 的患者在手术期间表现出类似的外科手术前细胞因子反应,与手术期间的健康对照. 这表明,尽管存在潜在的神经炎症,PD中对手术的急性炎症反应并未在全球范围内放大.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 麻醉学 麻醉学
背景情况:
- 神经炎症是帕金森病 (PD) 发病的一个关键因素.
- 在PD患者中,外科手术期间的免疫反应尚不清楚.
- 这项研究检查了PD患者与健康对照 (HCs) 之间的手术周围的细胞因子变化.
研究的目的:
- 为了研究和比较帕金森病患者和接受骨科手术的健康对照患者的外科手术前细胞因子概况.
- 为了确定PD是否会影响对全身麻醉和手术的急性炎症反应.
主要方法:
- 与25名PD患者和25名接受下肢整形手术的HC进行前性试点观察性研究.
- 血清细胞因子 (IL-6,IL-8,VEGF,MCP-1,HMGB1,S100B,PARK7) 在麻醉前 (PRE) 和手术后24小时 (POST) 测量.
- 统计分析包括独立和配对的t测试,以比较组和术后变化.
主要成果:
- 干白素-6 (IL-6) 在手术后的PD和HC组中同样增加.
- 在PD患者中,白内素-8 (IL-8) 的含量较高,但术后变化是可比的.
- 血管内皮生长因子 (VEGF) 在PD患者但不是HC患者下降;S100B和PARK7在HC患者但不是PD患者的术后增加.
- 对于MCP-1和HMGB1.1,没有观察到显著的术后变化.
结论:
- 在PD患者中,外科手术期间的细胞因子反应在很大程度上与HCs相似.
- 在PD患者中没有检测到急性手术炎症反应的疾病特异放大.
- 研究结果表明,在帕金森病中,外科手术期间的免疫激活是选择性的,而不是全球性的.
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Neural Regulation
43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K
COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
Inflammatory Bowel Disease IV: Pharmacological Management
860
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
860

